Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker GLUE
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Markus Warmuth Officer | GLUE Monte Rosa Therapeutics, Inc. | 9,500 | $220.2K | — | Jul 16, 2026 | Form 4 ↗ 1 day later · 9,500 shares | Form 144 ↗ |
| Jul 15, 2026 | Jennifer Champoux Officer | GLUE Monte Rosa Therapeutics, Inc. | 4,351 | $101.7K | 10b5-1 | Jul 15, 2026 | Form 4 ↗ 1 day later · 4,351 shares | Form 144 ↗ |
| Jun 30, 2026 | Filip Janku Officer | GLUE Monte Rosa Therapeutics, Inc. | 5,407 | $129.2K | 10b5-1 | Jun 30, 2026 | Form 4 ↗ 1 day later · 5,407 shares | Form 144 ↗ |
| Jun 29, 2026 | Filip Janku Officer | GLUE Monte Rosa Therapeutics, Inc. | 6,000 | $133.7K | 10b5-1 | Jun 29, 2026 | Form 4 ↗ 1 day later · 6,000 shares | Form 144 ↗ |
| Jun 29, 2026 | Anthony M Manning Director | GLUE Monte Rosa Therapeutics, Inc. | 10,000 | $231.1K | — | Jun 29, 2026 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Jun 24, 2026 | Filip Janku Officer | GLUE Monte Rosa Therapeutics, Inc. | 30,000 | $621.3K | 10b5-1 | Jun 24, 2026 | Form 4 ↗ 1 day later · 41,845 shares | Form 144 ↗ |
| Jun 23, 2026 | Jennifer Champoux Officer | GLUE Monte Rosa Therapeutics, Inc. | 2,175 | $40.0K | 10b5-1 | Jun 23, 2026 | Form 4 ↗ 2 days later · 2,175 shares | Form 144 ↗ |
| Jun 23, 2026 | Filip Janku Officer | GLUE Monte Rosa Therapeutics, Inc. | 11,845 | $221.1K | 10b5-1 | Jun 23, 2026 | Form 4 ↗ 2 days later · 41,845 shares | Form 144 ↗ |
| Jun 23, 2026 | Edmund Dunn Officer | GLUE Monte Rosa Therapeutics, Inc. | 16,665 | $345.0K | — | Jun 23, 2026 | — | Form 144 ↗ |
| Jun 17, 2026 | Jennifer Champoux Officer | GLUE Monte Rosa Therapeutics, Inc. | 2,176 | $39.0K | 10b5-1 | Jun 17, 2026 | Form 4 ↗ 1 day later · 2,176 shares | Form 144 ↗ |
| Jun 2, 2026 amended | Warmuth Markus Officer | GLUE Monte Rosa Therapeutics, Inc. | 5,467 | $103.4K | 10b5-1 | May 1, 2026 | Form 4 ↗ 45 days later · 9,500 shares | Form 144/A ↗ |
| Jun 1, 2026 | Warmuth Markus Officer | GLUE Monte Rosa Therapeutics, Inc. | 5,466 | $106.3K | 10b5-1 | Jun 1, 2026 | Form 4 ↗ 1 day later · 5,466 shares | Form 144 ↗ |
| May 29, 2026 | Sharon Townson Officer | GLUE Monte Rosa Therapeutics, Inc. | 24,000 | $465.4K | 10b5-1 | May 29, 2026 | Form 4 ↗ 3 days later · 6,000 shares | Form 144 ↗ |
| May 27, 2026 | Jennifer Champoux Officer | GLUE Monte Rosa Therapeutics, Inc. | 2,175 | $42.0K | 10b5-1 | May 27, 2026 | Form 4 ↗ 1 day later · 2,175 shares | Form 144 ↗ |
| May 22, 2026 | Jennifer Champoux Officer | GLUE Monte Rosa Therapeutics, Inc. | 2,176 | $40.7K | 10b5-1 | May 22, 2026 | Form 4 ↗ 4 days later · 2,176 shares | Form 144 ↗ |
| May 21, 2026 | Anthony M Manning Director | GLUE Monte Rosa Therapeutics, Inc. | 10,000 | $180.1K | — | May 21, 2026 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| May 1, 2026 | Warmuth Markus Officer | GLUE Monte Rosa Therapeutics, Inc. | 5,467 | $103.4M | 10b5-1 | May 1, 2026 | Form 4 ↗ 4 days later · 5,467 shares | Form 144 ↗ |
| Apr 16, 2026 | Edmund Dunn Officer | GLUE Monte Rosa Therapeutics, Inc. | 18,683 | $345.6K | — | Apr 16, 2026 | — | Form 144 ↗ |
| Apr 14, 2026 | Markus Warmuth Officer, Director | GLUE Monte Rosa Therapeutics, Inc. | 8,000 | $141.1K | — | Apr 14, 2026 | Form 4 ↗ 1 day later · 8,000 shares | Form 144 ↗ |
| Apr 13, 2026 | Edmund Dunn Officer | GLUE Monte Rosa Therapeutics, Inc. | 16,687 | $300.4K | — | Apr 13, 2026 | — | Form 144 ↗ |
| Apr 9, 2026 | Philip Nickson Officer | GLUE Monte Rosa Therapeutics, Inc. | 5,845 | $103.4K | — | Apr 9, 2026 | Form 4 ↗ 1 day later · 5,845 shares | Form 144 ↗ |
| Apr 8, 2026 | Edmund Dunn Officer | GLUE Monte Rosa Therapeutics, Inc. | 26,117 | $450.6K | — | Apr 8, 2026 | — | Form 144 ↗ |
| Mar 4, 2026 | Dunn Edmund Officer | GLUE Monte Rosa Therapeutics, Inc. | 139 | $2,482 | — | Mar 4, 2026 | Form 4 ↗ 1 day later · 139 shares | Form 144 ↗ |
| Mar 2, 2026 | Warmuth Markus Officer | GLUE Monte Rosa Therapeutics, Inc. | 5,466 | $98.0K | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 2 days later · 5,466 shares | Form 144 ↗ |
| Mar 2, 2026 | Edmund Dunn Officer | GLUE Monte Rosa Therapeutics, Inc. | 536 | $9,380 | — | Mar 2, 2026 | Form 4 ↗ same day · 25,700 shares | Form 144 ↗ |
| Feb 27, 2026 | Edmund Dunn Officer | GLUE Monte Rosa Therapeutics, Inc. | 25,164 | $455.5K | — | Feb 27, 2026 | Form 4 ↗ 3 days later · 25,700 shares | Form 144 ↗ |
| Feb 23, 2026 | Filip Janku Officer | GLUE Monte Rosa Therapeutics, Inc. | 9,189 | $179.2K | — | Feb 23, 2026 | Form 4 ↗ 1 day later · 9,189 shares | Form 144 ↗ |
| Jan 8, 2026 amended | Warmuth Markus Officer | GLUE Monte Rosa Therapeutics, Inc. | 5,466 | $128.4K | 10b5-1 | Jan 7, 2026 | Form 4 ↗ 55 days later · 5,466 shares | Form 144/A ↗ |
| Jan 7, 2026 | Warmuth Markus Officer | GLUE Monte Rosa Therapeutics, Inc. | 5,466 | $128.4K | 10b5-1 | Jan 7, 2026 | Form 4 ↗ 2 days later · 5,466 shares | Form 144 ↗ |
| Jan 5, 2026 | Warmuth Markus Officer, Director | GLUE Monte Rosa Therapeutics, Inc. | 10,135 | $153.8K | — | Jan 5, 2026 | Form 4 ↗ same day · 10,135 shares | Form 144 ↗ |
| Oct 28, 2024 | Owen B. Wallace Officer | GLUE Monte Rosa Therapeutics, Inc. | 20,000 | $240.0K | 10b5-1 | Oct 28, 2024 | — | Form 144 ↗ |
| May 1, 2024 | Jullian G. Jones Officer | GLUE Monte Rosa Therapeutics, Inc. | 105,072 | $559.0K | — | May 1, 2024 | — | Form 144 ↗ |
| Apr 10, 2024 | Jullian G. Jones Officer | GLUE Monte Rosa Therapeutics, Inc. | 103,548 | $813.9K | — | Apr 10, 2024 | — | Form 144 ↗ |
| Aug 15, 2023 | Tamboli Ajim Recently departed CFO | GLUE Monte Rosa Therapeutics, Inc. | 411,861 | $2.7M | — | Aug 15, 2023 | — | Form 144 ↗ |
34 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:00 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances